US Authorities Reject Approval of MDMA-Based PTSD Treatment
The US Food and Drug Administration (FDA) has rejected a treatment for post-traumatic stress disorder (PTSD) based on MDMA, commonly known as ecstasy, according to a statement from Lekos Therapeutics, the developer of the treatment.
The US…
اقرأ أكثر...
اقرأ أكثر...